1. bookVolume 62 (2018): Issue 4 (December 2018)
Journal Details
First Published
30 Mar 2016
Publication timeframe
4 times per year
access type Open Access

Role of Mesenchymal Stem Cells—Derived Exosomes in Osteoarthritis Treatment

Published Online: 31 Dec 2018
Volume & Issue: Volume 62 (2018) - Issue 4 (December 2018)
Page range: 19 - 23
Received: 17 Oct 2018
Accepted: 12 Nov 2018
Journal Details
First Published
30 Mar 2016
Publication timeframe
4 times per year

Exosomes are nanovesicles that are involved in inter-cellular communication and are secreted by many types of cells. Exosomes secreted by stem cells can effectively transport bioactive proteins, messenger ribonucleic acids (mRNAs) and microribonucleic acids (miRNAs) organelles and play important roles in intercellular communication and the regulation of tissue regeneration. This transfer of bioactive molecules plays a main role in: tumor invasion and metastasis, immune and inflammation modulation, epithelial-mesenchymal transition and neurobiology. Mesenchymal Stem Cells (MSC) exosomes provide new perspectives for the development of an off-the-shelf and cell-free MSC therapy for the treatment of cartilage injuries and osteoarthritis. This report describes the progress in exosome studies and potential clinical use for osteoarthritis treatment.


1. Admyre, C., Grunewald, J., Thyberg, J., Gripenbäck, S., Tornling G., Eklund A., 2003: Exosomes with major histo-compatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J., 22, 578—583.10.1183/09031936.03.00041703Search in Google Scholar

2. Bruno, S., Grange, C., Deregibus, M. C., 2009: Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol., 20, 1053—1067.10.1681/ASN.2008070798Search in Google Scholar

3. Caby, M. P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., Bonnerot, C., 2005: Exosomal-like vesicles are present in human blood plasma. Int. Immunol., 17, 879—887.10.1093/intimm/dxh267Search in Google Scholar

4. Clayton, A., Al-Taei, S., Webber, J., Mason, M. D., Tabi, Z., 2011: Cancer exosomes express CD39 and CD73, which suppress t cells through adenosine production. J. Immunol., 187, 676—683.10.4049/jimmunol.1003884Search in Google Scholar

5. Cosenza, S., Ruiz, M., Toupet, K., Jorgensen, Ch., Noël, D., 2017: Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Scientific Reports, 7, 16214.10.1038/s41598-017-15376-8Search in Google Scholar

6. De Bari, C., Roelofs, A. J., 2018: Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis. Current Opinion in Pharmacology, 40, 74—80.10.1016/j.coph.2018.03.009Search in Google Scholar

7. De Gassart, A., Geminard, C., Fevrier, B., Raposo, G., Vidal, M., 2003: Lipid raft-associated protein sorting in exosomes. Blood, 102, 4336—4344.10.1182/blood-2003-03-0871Search in Google Scholar

8. Duijvesz, D., Luider, T., Bangma, C. H., Jenster, G., 2011: Exosomes as biomarker treasure chests for prostate cancer. Eur. Urol., 59, 823—831.10.1016/j.eururo.2010.12.031Search in Google Scholar

9. Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., 2004: Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. USA, 101, 9683—9688.10.1073/pnas.0308413101Search in Google Scholar

10. Ge, Z., Hu, Y., Heng, B. C., Yang, Z., Ouyang, H., Lee, E. H., et al., 2006: Osteoarthritis and therapy. Arthritis Care Res., 55, 493—500.10.1002/art.21994Search in Google Scholar

11. Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H.., Sixma, J. J., 1999: Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood, 94, 3791—3799.10.1182/blood.V94.11.3791.423a22_3791_3799Search in Google Scholar

12. Hu, G. W., Li, Q., Niu, X., Hu, B., Liu, J., Zhou, S. M., et al., 2015: Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res. Ther., 6, 10.10.1186/scrt546Search in Google Scholar

13. Lai, R. C., Arslan, F., Lee, M. M., 2010: Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res., 4, 214—222.10.1016/j.scr.2009.12.003Search in Google Scholar

14. Lai, R. C., Chen, T. S., Lim, S. K., 2011: Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen. Med., 6, 481—492.10.2217/rme.11.35Search in Google Scholar

15. Lai, R. C., Yeo, R. W., Lim, S. K., 2015: Mesenchymal stem cell exosomes. Semin. Cell Dev. Biol., 40, 82e88.10.1016/j.semcdb.2015.03.001Search in Google Scholar

16. Lai, R. C., Yeo, R. W., Tan, K. H., Lim, S. K., 2013: Exosomes for drug delivery — a novel application for the mesenchymal stem cell. Biotechnology Advances, 31, 543—551.10.1016/j.biotechadv.2012.08.008Search in Google Scholar

17. Lee, C., Mitsialis, S. A., Aslam, M., 2012: Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation, 126, 2601—2611.10.1161/CIRCULATIONAHA.112.114173Search in Google Scholar

18. Liu, X., Li, Q., Niu, X., Hu, B., Chen, S., Song, W., et al., 2017: Exosomes secreted from human-induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis. Int. J. Biol. Sci., 13, 232—244.10.7150/ijbs.16951Search in Google Scholar

19. Loeser, R. F., Goldring, S. R., Scanzello, C. R., Goldring, M. B., 2012: Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum., 64, 1697—1707.10.1002/art.34453Search in Google Scholar

20. Mamidi, M. K., Das, A. K., Zakaria, Z., Bhonde, R., 2016: Mesenchymal stromal cells for cartilage repair in osteoarthritis. Osteoarthritis and Cartilage, 24, 1307e1316.10.1016/j.joca.2016.03.003Search in Google Scholar

21. Maumus, M., Jorgensen, C., Noël, D., 2013: Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes. Biochemie, 95, 2229e2234.10.1016/j.biochi.2013.04.017Search in Google Scholar

22. Meirelles, L. S., Fontes, A. M., Covas, D. T., Caplan, A. I., 2009: Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev., 20, 419—427.10.1016/j.cytogfr.2009.10.002Search in Google Scholar

23. Morishita, M., Takahashi, Y., Nishikawa, M., Takakura, Y., 2017: Pharmacokinetics of exosomes – an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics. J. Pharm. Sci., 106, 2265—2269.10.1016/j.xphs.2017.02.030Search in Google Scholar

24. Pan, B. T., Johnstone, R. M., 1983: Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell, 33, 967—978.10.1016/0092-8674(83)90040-5Search in Google Scholar

25. Peters, P. J., Geuze, H. J., Van Der Donk, H. A., Slot, J. W., Griffith, J. M., Stam, N. J., 1989: Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur. J. Immunol., 19, 1469—1475.10.1002/eji.1830190819Search in Google Scholar

26. Pisitkun, T., Shen, R. F., Knepper, M. A., 2004: Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U S A, 101, 13368—13373.10.1073/pnas.0403453101Search in Google Scholar

27. Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., Kloecker, G. H., 2009: Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cance., 10, 42—46.10.3816/CLC.2009.n.006Search in Google Scholar

28. Raposo, G., Nijman, H., Stoorvogel, W., Liejendekker,., Harding, C. V., Melief, C. J., 1996: B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med., 183, 1161—1172.10.1084/jem.183.3.1161Search in Google Scholar

29. Raposo, G., Tenza, D., Mecheri, S., Peronet, R., Bonnerot, C., Desaymard, C., 1997: Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell., 8, 2631—2645.10.1091/mbc.8.12.2631Search in Google Scholar

30. Sampson, S., Botto-van Bemden, A., Aufieroet, D., 2015: Stem cell therapies for treatment of cartilage and bone disorders: Osteoarthritis, avascular necrosis, and non-union fractures. PMR, 7, S26—S32.10.1016/j.pmrj.2015.01.023Search in Google Scholar

31. Skog, J., Wurdinger, T., Van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., 2008: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol., 10, 1470—1476.10.1038/ncb1800Search in Google Scholar

32. Sokolova, V., Ludwig, A. K., Hornung, S., Rotan, O., Horn, P. A., Epple, M., 2011: Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces, 87, 146—150.10.1016/j.colsurfb.2011.05.013Search in Google Scholar

33. Sullivan, R., Saez, F., Girouard, J., Frenette, G., 2005: Role of exosomes in sperm maturation during the transit along the male reproductive tract. Blood Cells Mol. Dis., 35, 1—10.10.1016/j.bcmd.2005.03.005Search in Google Scholar

34. Tao, S., Yuan, T., Zhang, Y., Yin, W., Guo, S., Zhang, Ch., 2017: Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics, 7, 180—195.10.7150/thno.17133Search in Google Scholar

35. Thery, C., Ostrowski, M., Segura, E., 2009: Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol., 9, 581—593.10.1038/nri2567Search in Google Scholar

36. Toha, W. S., Lai, R. C., Huib, J. H. P., Limd, S. K., 2017: MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. Seminars in Cell and Developmental Biology, 67, 56—64.10.1016/j.semcdb.2016.11.008Search in Google Scholar

37. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., 2001: Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med., 7, 297—303.10.1038/85438Search in Google Scholar

38. Wu, L., Prins, H.-J., Helder, M. N., van Blitterswijk, C. A., Karperien, M., 2012: Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng. A., 18, 1542—1551.10.1089/ten.tea.2011.0715Search in Google Scholar

39. Wu, L., Leijten, J. C. H., Georgi, N., Post, J. N., van Blitterswijk, C. A. Karperien, M., 2011: Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. Tissue Eng. A., 17, 1425—1436.10.1089/ten.tea.2010.0517Search in Google Scholar

40. Wubbolts, R., Leckie, R. S., Veenhuizen, P. T., Schwarz-mann, G., Mobius, W., Hoernschemeyer, J., 2003: Proteomic and biochemical analyses of human B cell-derived exosomes. J. Biol. Chem., 278, 10963—10972.10.1074/jbc.M207550200Search in Google Scholar

41. Xin, H., Li, Y., Buller, B., 2012: Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells, 30, 1556—1564.10.1002/stem.1129Search in Google Scholar

42. Zhang, S., Chuah, S. J., Lai, R. C., Hui, S. K., Toh, W. S., 2018: MSC exosomes mediate cartilage by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials, 156, 16—27.10.1016/j.biomaterials.2017.11.028Search in Google Scholar

43. Zhang, S., Chu, W. C., Lai, R. C., Lim, S. K., Hui, J. H., Toh, W. S., 2016: Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthr. Cartil., 24, 2135e2140.10.1016/j.joca.2016.06.022Search in Google Scholar

44. Zhu, Y., Wang, Y., Zhao, B., Niu, X., Hu, B., Li, Q., et al., 2017: Comparison of exosomes secreted by induced pluripo-tent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Research and Therapy, 8, 64.10.1186/s13287-017-0510-9Search in Google Scholar

45. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., 1998: Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med., 4, 594—600.10.1038/nm0598-594Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo